Viewing nowCombinationVystin Tablet 10/10 mg
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 201601728 · Approved 2016.03.31 · Insurance code 657805810
Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia
This medication is used as an adjunct to dietary therapy to reduce elevated total cholesterol, LDL-cholesterol, Apo B, and triglycerides, and to increase HDL-cholesterol in patients with primary hypercholesterolemia and mixed hyperlipidemia. It is also prescribed as an adjunct to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia or used alone when other treatments are not effective. It is administered along with appropriate dietary therapy to reduce the risk of atherosclerotic vascular diseases due to hypercholesterolemia and is used when there is insufficient response to non-drug therapy. It is important to identify secondary causes such as diabetes and hypothyroidism and treat them if necessary before administration. Regular lipid testing should be conducted during treatment to monitor total cholesterol, LDL, HDL, and triglyceride levels. This medication aids in improving dyslipidemia and preventing cardiovascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.
This medication may cause muscle-related side effects such as myopathy or rhabdomyolysis, so notify a doctor immediately if muscle pain, weakness, or any unusual symptoms occur. Caution is especially needed when taking high doses or in combination with other medications, as these risks can be increased. Patients allergic to any component of this medication, with poor liver function, pregnant or breastfeeding women, and those taking specific medications (e.g., strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, danazol) should not use this medication. Patients with muscle weakness or a history of muscle problems due to statin medications should use this medication with caution. There may be liver function abnormalities during use of this medication, so regular liver function tests are necessary, and patients with a history of liver disease should be especially cautious. In addition, there are several medications that may interact with this drug, so consult a doctor or pharmacist if taking other medications. Women who are pregnant or plan to become pregnant should not take this medication, and if pregnancy occurs during use, it should be discontinued immediately. It is also recommended that breastfeeding women stop breastfeeding while taking this medication. Special attention is required when administering to children or the elderly, as the safety and efficacy in pediatric patients have not been sufficiently proven. In the case of overdose, there is no specific antidote, so general treatment based on symptoms is necessary. This medication helps in the prevention of cardiovascular diseases, but patients at risk of diabetes should regularly check their blood sugar levels.
Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver amino transferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, drug reactions accompanied by systemic symptoms, erythema multiforme, myasthenia, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, taste disorder, oculomotor dysfunction, facial weakness, tremor, peripheral neuropathy, peripheral nerve palsy, mental disorders, anxiety, sleep disturbances, memory decline, forgetfulness, amnesia, memory impairment, confusion, interstitial lung disease, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, arthritis, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, fulminant hepatic necrosis, liver cancer, liver failure, appetite loss, vomiting, alopecia, various skin changes, lichenoid drug rash, gynecomastia, decreased libido, erectile dysfunction, ocular muscle paralysis, anemia, elevated amino transferases, increased ALP, elevated ɤ-GT, increased bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, transient liver function test abnormalities, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, elevated serum creatine phosphokinase, weight loss
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent exposure to air or moisture. It is recommended to store it at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the drug's effectiveness and ensure safe use.
Biconvex rectangular tablets, white to light yellow
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.